Back
Chicago Atlantic Real Estate Finance Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
15
REFI
Chicago Atlantic Real Estate Finance
Last Price:
16.11
Seasonality Move:
1.74%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
43.34
Seasonality Move:
-15.89%
Sell
15
Chicago Atlantic Real Estate Finance (REFI)
is a Sell
Is Chicago Atlantic Real Estate Finance a Buy, Sell or Hold?
- The current Chicago Atlantic Real Estate Finance [REFI] share price is $16.11. The Score for REFI is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- REFI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $44.00. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REFI Stock Price Chart
What is Chicago Atlantic Real Estate Finance's stock price today?
-
The Chicago Atlantic Real Estate Finance share price today is $16.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REFI is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $44.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
REFI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 66.7 | Buy |
Chaikin Money Flow: | 19245 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.29 - 15.97) | Buy |
Bollinger Bands (100): | (15.35 - 15.97) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.5 | Buy |
Relative Strength Index (14 RSI): | 58.93 | Buy |
Chaikin Money Flow: | 115403 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.12 - 49.42) | Buy |
Bollinger Bands (100): | (-5.11 - 34.85) | Buy |
REFI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.02 | Buy |
20-day SMA: | 15.73 | Buy |
50-day SMA: | 15.61 | Buy |
200-day SMA: | 15.71 | Buy |
8-day EMA: | 16 | Buy |
20-day EMA: | 15.81 | Buy |
50-day EMA: | 15.68 | Buy |
200-day EMA: | 15.63 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.17 | Buy |
20-day SMA: | 42.3 | Buy |
50-day SMA: | 28.61 | Buy |
200-day SMA: | 8.06 | Buy |
8-day EMA: | 39.27 | Buy |
20-day EMA: | 39.13 | Buy |
50-day EMA: | 31.07 | Buy |
200-day EMA: | 12.97 | Buy |
Chicago Atlantic Real Estate Finance Earnings Growth & REFI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Chicago Atlantic Real Estate Finance Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |